NEW YORK, Aug 9 – Pharmacogenomics company Visible Genetics of Toronto said its second quarter revenues increased to $3.9 million, compared with $3.4 million in the year ago period, as sales of genotyping kits rose 52 percent. 

The company said its total expenses for the quarter rose to $11.3 million from $10.5 million, mostly as the result of increased expenditures stemming from the startup of its kit manufacturing facility in Atlanta as well as consolidation costs and higher sales and marketing expenses.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.